Clinical trials
Non-Muscle Invasive Bladder Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 9 |
| 2024 | 11 |
| 2025 | 7 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
| Unknown status | 8 |
| Not yet recruiting | 7 |
| Active, not recruiting | 4 |
| Completed | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 4 |
| Fudan University | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Tianjin Medical University Second Hospital | 3 |
| Jiangsu Yahong Meditech Co., Ltd aka Asieris | 2 |
| Binhui Biopharmaceutical Co., Ltd. | 1 |
| Bristol-Myers Squibb | 1 |
| Changhai Hospital | 1 |
| Chengdu CoenBiotech Co., Ltd | 1 |
| Ding-Wei Ye | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 44 |
| Urinary Bladder Neoplasms | 12 |
| Carcinoma in Situ | 2 |
| Fanconi Syndrome | 2 |
| Neoplasms | 2 |
| Carcinoma, Transitional Cell | 1 |
| Disease | 1 |
| Neoplasm Metastasis | 1 |
| Pseudomonas Infections | 1 |
| Ureteral Neoplasms | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.